Insider Transactions Reported by 22 Insiders of Nuvalent, Inc.

Symbol
NUVL on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Nuvalent, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
James E. Flynn Director, Director by Deputization, 10%+ Owner $1,639,268,060 -$70,874,975 -4.1% 24 Nov 2025
Matthew Shair Director $174,338,383 -$7,158,178 -3.9% 24 Nov 2025
Andrew Hack Director $127,579,408 11 Dec 2024
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10%+ Owner $68,348,670 02 Aug 2021
DEERFIELD PARTNERS, L.P. Director, Director by Deputization, 10%+ Owner $49,491,000 03 Nov 2022
James Richard Porter President and CEO, Director $32,679,903 -$23,544,569 -42% 05 Jan 2026
Alexandra Balcom Chief Financial Officer $9,981,946 -$14,555,869 -59% 05 Jan 2026
Henry E. Pelish Chief Scientific Officer $8,388,082 -$4,873,320 -37% 05 Jan 2026
Christopher Durant Turner Chief Medical Officer $7,305,924 -$721,320 -9% 05 Jan 2026
Deborah Ann Miller Chief Legal Officer $5,998,643 -$9,498,054 -61% 05 Jan 2026
Darlene Noci Chief Development Officer $5,846,047 -$6,554,044 -53% 05 Jan 2026
Grant C. Bogle Director $390,111 18 Jun 2025
Sapna Srivastava Director $343,341 18 Jun 2025
Anna Protopapas Director $343,341 18 Jun 2025
Joseph Pearlberg Director $343,341 18 Jun 2025
Cameron Wheeler Director $343,341 18 Jun 2025
Michael L. Meyers Director $343,341 18 Jun 2025
Ron Squarer Director $309,403 10 Dec 2025
Christy J. Oliger Director $264,945 18 Jun 2025
Emily Conley Director $213,145 23 Aug 2024
Dwight Gary Gilliland Director $205,743 12 Jun 2024
Robert Bowers Jackson Director 28 Jul 2021

Recent Insider Transactions by Companies or Individuals for Nuvalent, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.